Quorum sensing (QS) contributes to the virulence of Pseudomonas aeruginosa and Burkholderia cepacia complex lung infections. P. aeruginosa QS mutants are frequently isolated from patients with cystic fibrosis. The objective of this study was to determine whether similar adaptations occur over time in B. cepacia complex isolates. Forty-five Burkholderia multivorans and Burkholderia cenocepacia sequential isolates from patients with cystic fibrosis were analyzed for N-acyl-homoserine lactone activity. All but one isolate produced N-acylhomoserine lactones. The B. cenocepacia N-acyl-homoserine lactone-negative isolate contained mutations in cepR and cciR. Growth competition assays were performed that compared B. cenocepacia clinical and laboratory defined wild-type and QS mutants. Survival of the laboratory wild-type and QS mutants varied, dependent on the mutation. The clinical wild-type isolate demonstrated a growth advantage over its QS mutant. These data suggest that there is a selective advantage for strains with QS systems and that QS mutations do not occur at a high frequency in B. cepacia complex isolates.
Quorum sensing (QS) contributes to the virulence of Pseudomonas aeruginosa and Burkholderia cepacia complex lung infections. P. aeruginosa QS mutants are frequently isolated from patients with cystic fibrosis. The objective of this study was to determine whether similar adaptations occur over time in B. cepacia complex isolates. Forty-five Burkholderia multivorans and Burkholderia cenocepacia sequential isolates from patients with cystic fibrosis were analyzed for N-acyl-homoserine lactone activity. All but one isolate produced N-acylhomoserine lactones. The B. cenocepacia N-acyl-homoserine lactone-negative isolate contained mutations in cepR and cciR. Growth competition assays were performed that compared B. cenocepacia clinical and laboratory defined wild-type and QS mutants. Survival of the laboratory wild-type and QS mutants varied, dependent on the mutation. The clinical wild-type isolate demonstrated a growth advantage over its QS mutant. These data suggest that there is a selective advantage for strains with QS systems and that QS mutations do not occur at a high frequency in B. cepacia complex isolates.
Cystic fibrosis (CF) is an autosomal recessive disorder affecting 1:3600 live births in Canada [1] . Pulmonary disease is the most common cause (.90 %) of morbidity and mortality among patients with CF [2] . The most common CF pathogen is Pseudomonas aeruginosa; however, infection with Burkholderia cepacia complex (Bcc) is a significant cause of death in patients with CF. The Bcc comprises 17 closely related species, all with the potential to infect the lungs of patients with CF [3] [4] [5] [6] .
The 2 most clinically relevant species are Burkholderia multivorans and Burkholderia cenocepacia, which account for .90% of Bcc infections in patients with CF [7] [8] [9] . B. multivorans and B. cenocepacia produce a variety of virulence factors that are important for establishing and maintaining lung infection [10] .
Bcc regulates the expression of several virulence factors by a cell-cell communication system known as quorum sensing (QS). QS involves the production of N-acyl-homoserine lactones (AHLs), which are signaling molecules that bind to transcriptional regulators and modulate gene expression. The CepIR QS system is a global regulatory system present in all Bcc species [11] . B. cenocepacia strains contain an AHL-independent CepR2 QS system that is not found in other Bcc [12] . B. cenocepacia strains that contain the cenocepacia island (cci) also have the CciIR QS system [13] . B. cenocepacia QS systems regulate several virulence factor genes, including the biosynthesis genes for siderophores [12, 14] ; type II, III [15] , and VI secretion [16] ; zinc metalloproteases; and genes involved in motility [16] . The CepIR QS system is important for virulence in several experimental infection models [17] [18] [19] [20] [21] , whereas cciI has been shown to contribute to virulence in a chronic respiratory infection model [13] . The B. multivorans CepIR system produces the same AHLs as B. cenocepacia [22] ; however, QS-regulated genes have not been specifically identified. Bmul3737 has been annotated as an orphan LuxR homologue in the ATCC17616 genome, but its role in QS has not been characterized.
P. aeruginosa has 2 QS systems known as the LasIR and RhlIR systems. P. aeruginosa lasR mutants have been recovered from the airways of chronically infected patients with CF [23] [24] [25] . Smith et al (2006) [22] compared genetically related isolates from the same patient with CF at 6 and 96 months after colonization. Many mutations were identified in the latter isolate in genes involved in O-antigen biosynthesis, type III secretion, multidrug efflux pumps, QS, motility and iron acquisition. Selected genes were sequenced from P. aeruginosa isolates from an additional 29 chronically infected patients with CF to determine the frequency of mutations in these genes. The most frequent mutations were identified in lasR and the mexA and mexZ efflux pump genes, occurring in 18 of 29 patients. Mutations in lasR ranged from single base changes to large (.100 genes) insertions and/or deletions. Approximately two-thirds of the mutations would result in a loss of LasR function. Wilder et al (2009) [24] examined multiple P. aeruginosa isolates from the same CF sputum samples and found a diversity of QS phenotypes in a single patient, including QS-proficient and -deficient strains. Several isolates contained loss of function mutations in either the lasI or rhlI genes. Hoffman et al (2009) [25] reported that 31% of CF isolates in an archived strain collection contained lasR mutations. These studies suggest that there is a selective pressure to generate QS mutants over the course of chronic lung infections.
P. aeruginosa QS systems regulate a variety of energydependent systems and protective functions [26, 27] that may impose a metabolic burden [28, 29] . Therefore, in a mixed population with wild-type (WT) strains, lasR mutants could exploit the cooperative signaling and exoproducts produced by the slower growing QS-proficient strains and become more prevalent [29, 30] .
Because little is known about the prevalence of Bcc QS mutants in chronically infected patients with CF, the objective of the present study was to determine whether QS gene mutations occur in B. multivorans or B. cenocepacia during chronic infection in patients with CF. We also investigated whether QS mutants have a growth advantage, compared with WT strains in vitro and in experimental lung infections.
MATERIALS AND METHODS

Bacterial Strains and Growth Conditions
Genetically related sequential isolates with the same random amplified polymorphic DNA (RAPD) type from 10 patients with CF chronically infected with B. multivorans and 12 patients chronically infected with B. cenocepacia were isolated from respiratory (sputum or throat) samples over a collection time of 2-16 years from 1988 through 2007 (Table 1 ). Thirteen isolates were from patients who subsequently died of infection, 12 were from patients with ongoing infections, and 1 was from a patient who eventually cleared the infection. The median collection time between isolates was 5.6 years for B. multivorans and 6.4 years for B. cenocepacia. Samples from patients with CF were obtained from routine clinic visits of patients attending either a pediatric clinic (British Columbia Children's Hospital, Vancouver, British Columbia, Canada) or an adult clinic (St. Paul's Hospital or Shaughnessy Hospital, Vancouver, British Columbia, Canada) or from patients hospitalized in Vancouver, British Columbia. Populations of isolates from single sputum culture samples from each of 2 patients were collected in 2009. Six different B. cenocepacia RAPD types and 8 different B. multivorans RAPD types were represented in the strains analyzed, with each sequential isolate from the same patient having the same RAPD type. Five of the 12 B. cenocepacia-infected patients were infected with strains belonging to the ET12 lineage (RAPD type 2) and, therefore, harbored the cci. B. cenocepacia types 1, 4, and 6 have also been reported to contain the cci [13] .
Laboratory strains used in this study are listed in Table 2 . QSdeletion mutants DcepRDcepR2DcciR and DcciIDcepI were constructed in B. cenocepacia K56-2, as described elsewhere [34, 35] . The DcepRDcepR2DcciR mutant was constructed by sequentially disrupting cepR2 and then cciR in the DcepR mutant [16] . The DcciIDcepI mutant was constructed by consecutively disrupting cciI [35] and then cepI [34] essentially, as described elsewhere. Inactivated cepI was amplified from pEXCEPI [32] . Primers are listed in Table 3 . Gene deletions were confirmed by polymerase chain reaction (PCR).
Strains were routinely grown in Luria-Bertani broth or trypticase soy broth at 37°C with shaking. The B. cenocepacia DcepIcciIb::Tp QS mutant was supplemented with 100 lg/mL of Tp. Agrobacterium tumefaciens A136 (pCF218) (pMV26) [18] was grown in trypticase soy broth at 28°C with 25 lg/mL of kanamycin and 4.5 lg/mL of tetracycline. For in vitro competition assays, bacteria were grown in synthetic CF sputum medium (SCFM) [36] with the absence of glucose and lactate. Bacterial growth was assessed by determining the optical density (OD) at 600 nm.
DNA Manipulations
DNA manipulations were performed as described elsewhere [37] . Plasmids were introduced into B. cenocepacia with use of electroporation [38] . Nucleotide sequencing was performed by University of Calgary Core DNA and Protein Services.
AHL Bioluminescence Assay
AHL activity was measured in liquid coculture assays [39] with the reporter strain A. tumefaciens A136 (pCF218) (pMV26), which detects octanoyl and hexanoyl N-acyl homoserine lactones produced by B. cenocepacia and B. multivorans [40] . Cultures were normalized to an OD 600nm of .05 prior to inoculation. Positive (K56-2) and negative (K56-2 DcepIcciIb::Tp [32] or K56-2 DcciIDcepI) controls were included for each assay. Plates were incubated at 29°C with constant shaking in a Wallac Victor 2 Model 1420 Multi-label Counter (Perkin-Elmer Life Sciences), and both the OD 600nm and luminescence were recorded (counts per second) at 30-min intervals. Each assay was performed in duplicate and repeated at least twice.
Sequencing of QS Genes from Bcc Isolates Recovered from Patients with CF
cepI and cepR were sequenced from all isolates in which the AHL activity was lower in the second isolate than in the first isolate. In addition, cepR2, cciI, and cciR were sequenced from all B. cenocepacia isolates with low AHL activity. PCR products for sequencing were amplified using primer sets listed in Table 3 . For patient 3 isolates, regions of the cciI gene were amplified and sequenced with primers listed in Table 3 .
Growth Competition Assays
In vivo growth competition assays were performed using the rat agar bead respiratory infection model [41] . Male SpragueDawley rats (150-180 g) were inoculated with 10 7 CFU in a 1:1 ratio of WT to QS mutant. Bacteria were recovered from lung homogenates 7 days after infection. Animal experiments were conducted according to the guidelines of the Canadian Council of Animal Care, and all protocols were approved by the University of Calgary Committee on Animal Care. For in vitro competition assays, overnight cultures were adjusted to OD 600nm of .05, and 1-mL WT and QS mutant in ratios between 1:1 and 1:60 was added to 9 mL SCFM and incubated for 24 h. Serial dilutions of each culture were spread onto Luria-Bertani agar. Colonies from each animal or in vitro assay were aseptically picked using a colony picker (JH Technologies) onto 96 well plates containing 150 lL Luria-Bertani broth and incubated for 24 h with shaking. The proportion of WT to mutant was determined using PCR analysis of the cepR gene. The competitive index, the outcome ratio of mutant to WT divided by the input ratio of mutant to WT, was determined.
Statistical Analyses
Values representing AHL activity were transformed to log values, and statistical significance was determined using PRISM 5 (GraphPad Software) by either Student's t test or analysis of variance with Dunnett's multiple comparisons posttest. P values ,.05 were considered to be statistically significant. AHL activity from B. multivorans or B. cenocepacia paired sequential isolates from patients with CF was measured over a 24-h period. To eliminate any variances between optimal time of expression of AHL activity, the maximum AHL activity (CPS:OD 600nm ) produced by each isolate was compared (Figure 1) . The mean 6 standard error of the mean (SEM) maximum AHL activity was 199700 6 34560 for B. cenocepacia isolates, which was significantly higher than the mean 6 SEM of 88910 6 26090 for the B. multivorans isolates (P , .05, by Student's t test). There was no difference between the mean 6 SEM AHL levels of the first and later B. multivorans or B. cenocepacia isolates (Figure 1 ). All isolates, with the exception of one B. cenocepacia isolate (from patient 3), had higher AHL activity than did the negative control (P , .05) ( Figure  1B) . A third isolate from patient 3 that obtained 10 months prior to the last isolate had AHL activity comparable to that in the initial isolate (Figure 2 ). These data indicate that, although an AHL-negative isolate was recovered from patient 3, isolates with functional QS genes had been maintained in this patient for at least 10 years.
Detection of QS Mutations in Bcc Sequential Isolates
CepR positively regulates cepI and cciIR transcription [14, 32] . Therefore, AHL-positive isolates had to have functional cepI and cepR genes. Because 1 isolate from patient 3 had no AHL activity, the 3 isolates from this patient were analyzed for potential QS genes mutations. The first and second isolates (C3921 and C8963) contained identical cepI and cepR genes; however, the later isolate, C9343, contained a 1.7 kb insertion sequence (IS) at nucleotide 649 in cepR. The partial amino acid sequence of the IS was 61% identical to the B. cenocepacia J2315 transposases BCAL 2498 and BCAL 2278, which are homologues of ISBcen18 of the IS256 family [42] . PCR with primers internal to the IS were used to determine whether this IS was also present in isolates C3921 and C8963. The same size PCR product was recovered from all 3 isolates, indicating that the IS was not the result of recent horizontal transfer. Several primer combinations were used to attempt to amplify the cciI and cciR region of C9343. Although some small internal fragments were detected, it was not possible to amplify an intact cciI, cciR, the N-terminal portion of cciR, or the upstream region containing the cciR promoter from strain C9343. This suggests that deletions and possibly rearrangements occurred in the cciIR locus in this strain. The cciIR genes were successfully amplified from strains C3921 and C8963. Genes BCAM0236 and BCAM0278, located on the ends of the cci, were successfully amplified from all 3 strains, indicating that at least some portions of the island are present in C9343. Although all B. multivorans isolates had AHL activity ( Figure 1B) , AHL levels in the first isolate from patient 13 were significantly greater than those in the later isolate (P , .01). The cepI and cepR sequences were identical in both patient 13 isolates, and therefore, the decrease in AHL activity in the second isolate was not attributable to mutations in these genes.
Comparison of AHL Activity by a Population of B. cenocepacia Isolates from a Single Patient Sputum Culture
Only 1 of 45 isolates from the 22 patients described above was found to harbor mutations in QS genes resulting in an inability to produce AHLs. Because it is possible that QS mutants might be present along with WT Bcc isolates in a chronically infected patient with CF, we screened the population of isolates recovered from the primary sputum culture plates from 2 patients infected with B. cenocepacia for AHL activity. All isolates tested produced more AHL than did the negative control, indicating that all isolates in the population had a functional QS system (Figure 3 ). All sputum culture isolates from patient 25 had similar AHL profiles to K56-2.
Isolates from patient 26 could be grouped into 2 AHL activity profiles; 4 isolates with a profile similar to K56-2 and the Detection of cepR mutant in competition assays [16] DW-cepR-XbaI-R2 GCACTCTAGACGCACGCTGCTGTCGAACGC remaining isolates producing AHLs at a later phase of growth. Representative strains from both profile types were examined for sequence differences in the cepI, cepR, and cepR2 genes. No variations were present, indicating that mutations in these genes are not responsible for the difference in AHL activity.
Competitive Index Analysis of WT and QS Mutant Isolates
The ability of B. cenocepacia QS mutants to compete with WT strains was determined in a chronic respiratory infection model and in synthetic CF sputum medium. When the strains were grown individually in broth culture, the K56-2 DcepR mutant grew slightly faster than did K56-2 in trypticase soy broth medium ( Figure 4A) , and C9343 had a slight growth advantage, compared with C3921 in SCFM ( Figure 4B ). For the in vivo competition analysis, rats were infected with agar beads containing a 1:1 ratio of WT to QS mutant ( Figure 4C ). The proportion of WT to QS mutants in the population of isolates cultured from lung homogenates was determined. K56-2 had a slight growth advantage, compared with its DcepR mutant but no significant growth difference from the K56-2 DcepRDcepR2DcciR mutant. Competition between the clinical isolates demonstrated that 98.5% of the colonies recovered from the lungs were C3921. There was a statistically significant difference between the competitive indices of the clinical WT and cepRcciIR mutant and that of K56-2 and its QS isogenic mutants (P , .05), suggesting that other genes in C9343 may contain deletions or have altered expression that contribute to its reduced survival. In vitro competition experiments between the WT and QS mutant strains in SCFM ( Figure 4D ) demonstrated that K56-2 slightly outgrew its DcepR mutant (1:1 inoculum ratio), comparable to the in vivo experiment. In contrast, the DcepRDcepR2DcciR mutant out-competed the K56-2 WT, although a higher initial inoculum ratio (4:1) may have contributed to this result. C3921 had a slight growth advantage over C9343. When an inoculum ratio of 1:60 DcepR mutant to WT was used, 100% of WT colonies were recovered (data not shown). Taken together, the in vivo and in vitro growth competition assays suggest that QS mutants do not have a selective growth advantage over WT strains. Figure 1 . The maximum N-acyl-homoserine lactone (AHL) activity detected from isolates recovered from patients with cystic fibrosis (CF) who were chronically infected with Burkholderia multivorans (A) and Burkholderia cenocepacia (B) with use of Agrobacterium tumefaciens A136 (pCF218) (pMV26) as the reporter system. K56-2 (shaded bar) and K56-2 DcepIcciIb::Tp (striped bar) were included as positive and negative controls, respectively. Values represent mean 6 standard error of the mean (SEM) of at least 2 independent experiments performed in duplicate. *Log mean 6 SEM AHL activity significantly different than negative control (P , .05; ANOVA, Dunnett's Multiple Comparison test). **Log mean 6 standard deviation AHL activity significantly different than negative control in at least 2 of 3 independent experiments (P ,.05). 
DISCUSSION
Although QS mutations can occur during Bcc chronic infection, the vast majority of isolates examined retained at least 1 functional QS system. Only 1 isolate from 22 patients was determined to harbor QS mutations that affected function, and it had mutations in both cepR and cciR. The frequency of P. aeruginosa lasR mutations among patients with CF, however, was reported to be .60% by Smith et al [23] . Hoffman et al (2009) [25] reported a 31% incidence of lasR mutations in 166 P. aeruginosa isolates from 58 patients with CF, compared with the 1 in 45 isolates or 2.2% prevalence of cepR mutations identified in the present study. We also analyzed the B. cenocepacia population of isolates from individual sputum samples from 2 patients and failed to identify any QS-deficient isolates, confirming the infrequency of Bcc QS mutants among isolates from the same sputum population (Figure 3) . A recent study examining P. aeruginosa populations in 8 patients with CF (mean of 17 isolates in each patient) demonstrated that 87% of patients were colonized with isolates harboring QS mutations [24] .
No cepI mutations were identified in any of the Bcc isolates analyzed, and the levels of AHL activity detected in the strains not analyzed for sequence mutations suggest that both cepR and cepI are functional. Mutations in lasR and rhlR genes were more frequently found in P. aeruginosa than were lasI or rhlI mutations [27, 43] . Most lasR mutations identified in P. aeruginosa isolates were predicted to be loss-of-function mutations [24] . Therefore, if loss-of-function mutations occurred at a similar frequency in Bcc chronic infections, we should have identified mutated isolates by screening for functional AHL activity.
Although B. cenocepacia C3921, C8963, and C9343 have similar pulse-field gel electrophoresis profiles [44] , several differences between the later 2 isolates have been recently reported [45] , suggesting that there may be other genome rearrangements in C9343 in addition to those identified in the cepR and cciIR loci; this may contribute to its reduced survival in the lung infection model. The IS element in C8963 cepR, ISBcen18, has not previously been reported to mediate genome rearrangement in B. cenocepacia, although ISBcen20 has been shown to be activated when exposed to oxidative stress in a CF isolate [46] . Our study suggests that ISBcen18 can also mobilize, although specific triggers have not been identified. Of interest, isolates from patients 25 and 26 were also found to have rearrangements or deletions in the cci, suggesting that this genomic island is not as stable in B. cenocepacia IIIA as originally reported (data not shown) [13] .
In contrast to some reports on P. aeruginosa QS mutants, that suggest generation, diversity, and survival of QS mutants are dependent on the local environment and that composition of culture medium can trigger the occurrence of P. aeruginosa lasR mutants in vitro [28, 29, 47, 48] , B. cenocepacia QS mutants do not appear to have a growth advantage over WT mutants either in chronic lung infections or in vitro cultures in SCFM. SCFM is a physiologically relevant defined medium using free amino acids as the principal carbon source and is similar to CF sputum with regard to composition, pH, and chloride concentration. [36] . K56-2 WT significantly out-competed K56-2DcepR but not K56-2 DcepRDcepR2DcciR in this medium. The C3921 WT outcompeted C9343 to almost significant levels, at least suggesting that C9343 does not have a growth advantage in vitro.
Our study demonstrates that, at least in the 2 most prevalent Bcc species, QS mutants seldom occur in the airways of chronically infected patients with CF. In vivo and in vitro analysis determined that, although QS mutants can survive in the presence of the WT strains, they are rarely able to outcompete the WT, indicating that chronic Bcc infections may require a functional QS system. Unlike P. aeruginosa, most Bcc strains, including B. multivorans, have a single QS system. Therefore, a functional CepIR system is critical for QS regulation of virulence genes. In B. cenocepacia strains that have both CepR and CciR, these QS systems inversely regulate most co-regulated genes [16] , and therefore, the 2 QS systems do not compensate for each other like RhlR and LasR, which more frequently commonly regulate their target genes. In addition, in contrast to P. aeruginosa, Bcc may cause invasive cepacia syndrome-type infections, even after prolonged chronic infection, which may require the maintenance or reactivation of QS-controlled virulence factor expression. Recent studies demonstrated that P. aeruginosa RhlR can activate LasR regulated genes in the absence of lasR and, therefore, bypass the lasR defect in QS regulation [49] . A recent study of P. aeruginosa CF isolates from different stages of chronic infection also determined that the rhl QS system was maintained significantly longer than was the las system; functional mutations in the las system occurred after a median time of 12 years after the onset of lung infection, whereas mutations resulting in a loss of both QS systems were not detected until 17 years after the initial infection [43] . Although the median interval between isolation of our strains was 5.6 years for B. multivorans and 6.4 years for B. cenocepacia, Bcc infections have been historically shorter than have P. aeruginosa infections because of the increased morbidity and mortality associated with these infections. Most lasR-defective strains continued to produce C4-HSL the AHL synthesized by rhlI and to produce rhlR-regulated virulence factors. Our data and those from Bjarnsholt et al. [43] suggest that QS-regulated virulence factors are important in both Bcc and P. aeruginosa chronic infections and that therapeutic strategies to interfere with QS systems or their targets might be affective for both acute and chronic CF respiratory infections. 
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